Skip to main content
C

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,504 across all filing types
Latest filing 2025-04-28 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders informing them that the 2024 Annual Report and Circular, Notice of Annual General Meeting and Proxy form, and the 2024 ESG Report have been published and are available on the company’s and HKEx’s websites. It provides instructions for requesting printed copies. This is not the actual annual report or ESG report itself, but rather an announcement of their publication and how to obtain them. Therefore, it falls under the “Report Publication Announcement” category (RPA).
2025-04-28 English
NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter to shareholders titled “Notice of Publication of 2024 Annual Report and Circular, Notice of Annual General Meeting and Proxy form and 2024 Environmental, Social and Governance Report.” It does not contain the actual annual report content but announces that these reports and related materials have been published on the company website and provides instructions for receiving printed copies. This matches the definition of a Report Publication Announcement (RPA).
2025-04-28 English
LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM
Regulatory Filings Classification · 1% confidence The document is a letter and reply form sent to shareholders to elect their preferred means of receiving future Corporate Communications (including the ESG Report). It does not itself contain financial results, proxy materials, or a full ESG report, nor does it announce a dividend, meeting results, or other specific corporate events. It is a shareholder communication requesting an instruction (an “Actionable Corporate Communication”) but does not match any more specific category. Therefore it falls into the fallback category for general regulatory/ shareholder filings: RNS.
2025-04-28 English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 30 MAY 2025 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a proxy form sent to shareholders to appoint proxies and vote on AGM resolutions (e.g., to receive audited statements, re-elect directors, approve mandates). This falls under Proxy Solicitation & Information Statement, as it solicits shareholder votes for the Annual General Meeting.
2025-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of Annual General Meeting, with agenda items, resolutions, proxy appointment instructions, and meeting particulars. It is sent to shareholders to provide information and request votes, matching the definition of a Proxy Solicitation & Information Statement rather than the meeting materials themselves (AGM-R) or the results. Therefore it should be classified as PSI.
2025-04-28 English
PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, MANDATE TO GRANT OPTIONS AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular containing the “Letter from the Board,” explanatory statements on proposed resolutions (general mandates to buy back and issue shares, grant options, re-election of directors), and the formal Notice of Annual General Meeting, together with a proxy form. It is distributed to shareholders to solicit their votes and provide detailed background on each resolution at the AGM. This matches the Proxy Solicitation & Information Statement category (PSI) rather than the AGM materials themselves or a full report.
2025-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.